Cambridge, Massachusetts-based Voyager Therapeutics, a gene therapy company focused on treating central nervous system diseases, has closed $60 million in Series B funding. Brookside Capital and Partner Fund Management led the round with participation from other investors that included Wellington Management Company LLP and Casdin Capital LLC.
2 min read · 13 April 2015
UK-based drug toxicity testing company Clyde Biosciences has secured 2 million pounds in Series A funding. Epidarex Capital led the round with participation from the Scottish Investment Bank and Glasgow University Holdings Ltd.
5 min read · 13 April 2015
Watertown, Massachusetts-based Blend Therapeutics Inc, a biopharmaceutical company focused on treating patients with solid tumor cancers, has named Drew Fromkin as president, CEO and a member of the company’s board of directors. Previously, Fromkin worked at Clinical Data Inc where he served as President and CEO. Blend Therapeutics' backers include Eminent Venture Capital, Flagship Ventures, NanoDimension and New Enterprise Associates.
5 min read · 13 April 2015
MPM Capital named Gregory Sieczkiewicz as managing director and chief counsel, intellectual property. The appointment is effective immediately. Previously, Sieczkiewicz worked at Flagship Ventures where he served as vice president of intellectual property.
2 min read · 13 April 2015
Austin, Texas-based Khorus, a business management software provider for CEOs, has secured $4 million in Series A funding. Khorus founder Joel Trammel and angel investor Tom Greig led the round.
2 min read · 13 April 2015
Boise, Idaho-based Cradlepoint, a provider of cloud-managed 4G LTE networking solutions, has raised $48 million in Series B funding. Sorenson Capital led the round with participation from Delta-v Capital and The CAPROCK Group. In addition to the funding, Sorenson Capital's LeGrand Lewis and Ron Mika have been added to Cradlepoint’s board of directors.
4 min read · 13 April 2015
Chicago-based weight loss solutions provider Retrofit has named Julie Newhouse Goldman as vice president of marketing and product management. Goldman is the former senior director, global brand strategy and leader of global wellness for the Wm. Wrigley Jr. Company. Retrofit's backers included Draper Fisher Jurvetson and Cambia Health Solutions.
3 min read · 10 April 2015
According to an SEC filing, SWaN & Legend Venture Partners is seeking to raise $150 million for its third fund. Based in Leesburg, Virginia, SWaN & Legend backs companies that build consumer brands "as well as the B2B companies that support them."
1 min read · 10 April 2015
Belgium-based laboratory software developer UgenTec has raised 1.35 million euros in overall funding. Of that amount, a Belgian investor group provided 1 million euros while IWT, a government agency for Innovation by Science and Technology, provided 250,000 euros. And, UgenTec received a loan in the amount of 100,000 euros from Belgian investment company LRM.
3 min read · 10 April 2015
Embera NeuroTherapeutics Inc, a biopharmaceutical company focused on treating addictions such as smoking and cocaine abuse, has secured $2 million in Series A-2 funding. The investors included HRA Pharma.
3 min read · 10 April 2015
